Yan Chen1, Yingying Sang1, Shoshana H Ballew1, Adrienne Tin1, Alex R Chang2, Kunihiro Matsushita1, Josef Coresh1, Kamyar Kalantar-Zadeh3, Miklos Z Molnar4, Morgan E Grams5. 1. Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD. 2. Division of Nephrology, Geisinger Health System, Danville, PA. 3. Harold Simmons Center for Chronic Disease Research & Epidemiology, University of California Irvine Medical Center, Irvine, CA; Division of Nephrology & Hypertension, University of California Irvine Medical Center, Orange, CA. 4. Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN; Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary. 5. Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD; Division of Nephrology, Department of Medicine, Johns Hopkins University, Baltimore, MD. Electronic address: mgrams2@jhmi.edu.
Abstract
BACKGROUND: Recent studies suggest that potassium levels may differ by race. The basis for these differences and whether associations between potassium levels and adverse outcomes differ by race are unknown. STUDY DESIGN: Observational study. SETTING & PARTICIPANTS: Associations between race and potassium level and the interaction of race and potassium level with outcomes were investigated in the Racial and Cardiovascular Risk Anomalies in Chronic Kidney Disease (RCAV) Study, a cohort of US veterans (N=2,662,462). Associations between African ancestry and potassium level were investigated in African Americans in the Atherosclerosis Risk in Communities (ARIC) Study (N=3,450). PREDICTORS: Race (African American vs non-African American and percent African ancestry) for cross-sectional analysis; serum potassium level for longitudinal analysis. OUTCOMES: Potassium level for cross-sectional analysis; mortality and end-stage renal disease for longitudinal analysis. RESULTS: The RCAV cohort was 18% African American (N=470,985). Potassium levels on average were 0.162mmol/L lower in African Americans compared with non-African Americans, with differences persisting after adjustment for demographics, comorbid conditions, and potassium-altering medication use. In the ARIC Study, higher African ancestry was related to lower potassium levels (-0.027mmol/L per each 10% African ancestry). In both race groups, higher and lower potassium levels were associated with mortality. Compared to potassium level of 4.2mmol/L, mortality risk associated with lower potassium levels was lower in African Americans versus non-African Americans, whereas mortality risk associated with higher levels was slightly greater. Risk relationships between potassium and end-stage renal disease were weaker, with no difference by race. LIMITATIONS: No data for potassium intake. CONCLUSIONS: African Americans had slightly lower serum potassium levels than non-African Americans. Consistent associations between potassium levels and percent African ancestry may suggest a genetic component to these differences. Higher and lower serum potassium levels were associated with mortality in both racial groups.
BACKGROUND: Recent studies suggest that potassium levels may differ by race. The basis for these differences and whether associations between potassium levels and adverse outcomes differ by race are unknown. STUDY DESIGN: Observational study. SETTING & PARTICIPANTS: Associations between race and potassium level and the interaction of race and potassium level with outcomes were investigated in the Racial and Cardiovascular Risk Anomalies in Chronic Kidney Disease (RCAV) Study, a cohort of US veterans (N=2,662,462). Associations between African ancestry and potassium level were investigated in African Americans in the Atherosclerosis Risk in Communities (ARIC) Study (N=3,450). PREDICTORS: Race (African American vs non-African American and percent African ancestry) for cross-sectional analysis; serum potassium level for longitudinal analysis. OUTCOMES: Potassium level for cross-sectional analysis; mortality and end-stage renal disease for longitudinal analysis. RESULTS: The RCAV cohort was 18% African American (N=470,985). Potassium levels on average were 0.162mmol/L lower in African Americans compared with non-African Americans, with differences persisting after adjustment for demographics, comorbid conditions, and potassium-altering medication use. In the ARIC Study, higher African ancestry was related to lower potassium levels (-0.027mmol/L per each 10% African ancestry). In both race groups, higher and lower potassium levels were associated with mortality. Compared to potassium level of 4.2mmol/L, mortality risk associated with lower potassium levels was lower in African Americans versus non-African Americans, whereas mortality risk associated with higher levels was slightly greater. Risk relationships between potassium and end-stage renal disease were weaker, with no difference by race. LIMITATIONS: No data for potassium intake. CONCLUSIONS: African Americans had slightly lower serum potassium levels than non-African Americans. Consistent associations between potassium levels and percent African ancestry may suggest a genetic component to these differences. Higher and lower serum potassium levels were associated with mortality in both racial groups.
Authors: Csaba P Kovesdy; Anthony J Bleyer; Miklos Z Molnar; Jennie Z Ma; John J Sim; William C Cushman; L Darryl Quarles; Kamyar Kalantar-Zadeh Journal: Ann Intern Med Date: 2013-08-20 Impact factor: 25.391
Authors: Orlando M Gutiérrez; Afshin Parsa; Tamara Isakova; Julia J Scialla; Jing Chen; John M Flack; Lisa C Nessel; Jayanta Gupta; Keith A Bellovich; Susan Steigerwalt; James H Sondheimer; Jackson T Wright; Harold I Feldman; John W Kusek; James P Lash; Myles Wolf Journal: Clin J Am Soc Nephrol Date: 2016-02-08 Impact factor: 8.237
Authors: Morgan E Grams; Yingying Sang; Josef Coresh; Shoshana H Ballew; Kunihiro Matsushita; Andrew S Levey; Tom H Greene; Miklos Z Molnar; Zoltan Szabo; Kamyar Kalantar-Zadeh; Csaba P Kovesdy Journal: J Am Soc Nephrol Date: 2016-02-08 Impact factor: 10.121
Authors: Nick Patterson; Neil Hattangadi; Barton Lane; Kirk E Lohmueller; David A Hafler; Jorge R Oksenberg; Stephen L Hauser; Michael W Smith; Stephen J O'Brien; David Altshuler; Mark J Daly; David Reich Journal: Am J Hum Genet Date: 2004-04-14 Impact factor: 11.025
Authors: Adrienne Tin; Anna Köttgen; Aaron R Folsom; Nisa M Maruthur; Salman M Tajuddin; Mike A Nalls; Michele K Evans; Alan B Zonderman; Christopher A Friedrich; Eric Boerwinkle; Josef Coresh; Wen Hong Linda Kao Journal: BMC Genet Date: 2015-05-29 Impact factor: 2.797
Authors: Fernanda A Goncalves; Jessica Santos de Jesus; Lilian Cordeiro; Maria Clara T Piraciaba; Luiza K R P de Araujo; Carolina Steller Wagner Martins; Maria Aparecida Dalboni; Benedito J Pereira; Bruno C Silva; Rosa Maria A Moysés; Hugo Abensur; Rosilene M Elias Journal: Int Urol Nephrol Date: 2020-02-03 Impact factor: 2.370
Authors: Lakshmi Manasa S Chekka; Arlene B Chapman; John G Gums; Rhonda M Cooper-DeHoff; Julie A Johnson Journal: Am J Med Date: 2021-01-09 Impact factor: 5.928
Authors: Michele Provenzano; Roberto Minutolo; Paolo Chiodini; Vincenzo Bellizzi; Felice Nappi; Domenico Russo; Silvio Borrelli; Carlo Garofalo; Carmela Iodice; Toni De Stefano; Giuseppe Conte; Hiddo J L Heerspink; Luca De Nicola Journal: J Clin Med Date: 2018-12-01 Impact factor: 4.241
Authors: Kunihiro Matsushita; Yingying Sang; Chao Yang; Shoshana H Ballew; Morgan E Grams; Josef Coresh; Miklos Z Molnar Journal: PLoS One Date: 2019-08-08 Impact factor: 3.240
Authors: Simon J Davies; Junhui Zhao; Hal Morgenstern; Jarcy Zee; Brian Bieber; Douglas S Fuller; James A Sloand; Andreas Vychytil; Hideki Kawanishi; David W Johnson; Angela Yee-Moon Wang; Talerngsak Kanjananbuch; Sarinya Boongird; Thyago P Moraes; Sunil V Badve; Ronald L Pisoni; Jeffrey Perl Journal: Kidney Int Rep Date: 2020-11-22